192 related articles for article (PubMed ID: 38308097)
1. A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.
Wang W; Gao Y; Xu J; Zou T; Yang B; Hu S; Cheng X; Xia Y; Zheng Q
Adv Sci (Weinh); 2024 Apr; 11(14):e2307143. PubMed ID: 38308097
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy for cholangiocarcinoma: overview and new developments.
Ortner MA
Curr Opin Gastroenterol; 2009 Sep; 25(5):472-6. PubMed ID: 19550314
[TBL] [Abstract][Full Text] [Related]
3. Advances in research and application of photodynamic therapy in cholangiocarcinoma (Review).
Li Y; Li Y; Song Y; Liu S
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38334150
[TBL] [Abstract][Full Text] [Related]
4. Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer
Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153
[No Abstract] [Full Text] [Related]
5. Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice.
Shiryaev AA; Musaev GK; Levkin VV; Reshetov IV; Loshchenov MV; Alekseeva PM; Volkov VV; Linkov KG; Makarov VI; Shchekoturov IO; Borodkin AV; Loschenov VB
Photodiagnosis Photodyn Ther; 2019 Jun; 26():218-223. PubMed ID: 30965145
[TBL] [Abstract][Full Text] [Related]
6. The role of photodynamic therapy for hilar cholangiocarcinoma.
Cheon YK
Korean J Intern Med; 2010 Dec; 25(4):345-52. PubMed ID: 21179270
[TBL] [Abstract][Full Text] [Related]
7. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W
Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475
[TBL] [Abstract][Full Text] [Related]
8. Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment.
He Z; Zhou H; Zhang Y; Du X; Liu S; Ji J; Yang X; Zhai G
Biomaterials; 2022 Nov; 290():121832. PubMed ID: 36228518
[TBL] [Abstract][Full Text] [Related]
9. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
10. Technology insight: Photodynamic therapy for cholangiocarcinoma.
Ortner MA; Dorta G
Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):459-67. PubMed ID: 16883350
[TBL] [Abstract][Full Text] [Related]
11. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
Weijer R; Broekgaarden M; van Golen RF; Bulle E; Nieuwenhuis E; Jongejan A; Moerland PD; van Kampen AH; van Gulik TM; Heger M
BMC Cancer; 2015 Dec; 15():1014. PubMed ID: 26705830
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers-Mediated Photodynamic Therapy.
Yu Q; Li X; Wang J; Guo L; Huang L; Gao W
Small; 2024 Apr; 20(16):e2305708. PubMed ID: 38018311
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.
Broekgaarden M; Weijer R; van Gulik TM; Hamblin MR; Heger M
Cancer Metastasis Rev; 2015 Dec; 34(4):643-90. PubMed ID: 26516076
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for unresectable cholangiocarcinoma.
Tomizawa Y; Tian J
Dig Dis Sci; 2012 Feb; 57(2):274-83. PubMed ID: 22057285
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells.
Kim CH; Chung CW; Lee HM; Kim DH; Kwak TW; Jeong YI; Kang DH
Int J Nanomedicine; 2013; 8():2173-86. PubMed ID: 23807846
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma.
Hong MJ; Cheon YK; Lee EJ; Lee TY; Shim CS
Gut Liver; 2014 May; 8(3):318-23. PubMed ID: 24827630
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
Tian S; Yong M; Zhu J; Zhang L; Pan L; Chen Q; Li KT; Kong YH; Jiang Y; Yu TH; Yu LH; Bai DQ
Anticancer Agents Med Chem; 2017; 17(13):1824-1836. PubMed ID: 28356018
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.
Wu H; Du X; Xu J; Kong X; Li Y; Liu D; Yang X; Ye L; Ji J; Xi Y; Zhai G
Acta Biomater; 2023 Feb; 157():551-565. PubMed ID: 36513248
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment.
Shim CS; Cheon YK; Cha SW; Bhandari S; Moon JH; Cho YD; Kim YS; Lee LS; Lee MS; Kim BS
Endoscopy; 2005 May; 37(5):425-33. PubMed ID: 15844020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
